CELC

Celcuity LLC is an innovative clinical-stage biotechnology firm based in Minneapolis, Minnesota, focused on revolutionizing cancer care through its unique technology platform that identifies cancer subtypes and develops targeted therapies. Utilizing its proprietary Celcuity technology, the company aims to pinpoint specific biological markers in cancer patients, enabling the delivery of personalized treatment solutions that enhance efficacy. With a robust drug development pipeline and a firm commitment to precision medicine, Celcuity is poised to lead advancements in oncology, addressing critical patient needs and positioning itself as a key player in the evolving landscape of cancer treatment.